2022
DOI: 10.1007/s00261-022-03738-4
|View full text |Cite
|
Sign up to set email alerts
|

Incremental value of PET primary lesion-based radiomics signature to conventional metabolic parameters and traditional risk factors for preoperative prediction of lymph node metastases in gastric cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 29 publications
0
1
0
Order By: Relevance
“…Xue et al ( 66 , 72 ) published two more studies in 2022 and 2023, respectively. In the first study, the authors enrolled 127 patients with pathologically confirmed GC who underwent preoperative 18F-fluorodeoxyglucose (18F-FDG) PET/CT, with the aim of building and validating an 18F-FDG PET-based radiomics nomogram to predict N2-3b LNM.…”
Section: Resultsmentioning
confidence: 99%
“…Xue et al ( 66 , 72 ) published two more studies in 2022 and 2023, respectively. In the first study, the authors enrolled 127 patients with pathologically confirmed GC who underwent preoperative 18F-fluorodeoxyglucose (18F-FDG) PET/CT, with the aim of building and validating an 18F-FDG PET-based radiomics nomogram to predict N2-3b LNM.…”
Section: Resultsmentioning
confidence: 99%